Cancer BiologybioRxivPreprint
Neolactotetraosylceramide: A novel non-invasive urinary biomarker for bladder cancer
Inês B. Moreira, Charlotte Rossdam, Julia Beimdiek…·Falk F. R. Buettner
This paper identifies neolactotetraosylceramide (nLc4) as a non-invasive urinary biomarker for bladder cancer, showing higher levels in cancer tissues and urine exosomes with high specificity.
1 citation